JLJay R. Laver

Jay R. Laver

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jay R. Laver has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Robert Charles Read

    NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK

    2 shared publications
  • Robert K. Poole

    Department of Molecular Biology and Biotechnology, The University of Sheffield, Sheffield, United Kingdom

    2 shared publications
  • Amy Dehn Lunn

    Department of Infection and Immunity The University of Sheffield Sheffield UK

    1 shared publication
  • James W. B. Moir

    Department of Biology

    1 shared publication
  • Laura J. Harrison

    Department of Infection and Immunity, The University of Sheffield, Sheffield, United Kingdom

    1 shared publication
  • Lesley A.H. Bowman

    Department of Molecular Biology and Biotechnology, The University of Sheffield, Sheffield, United Kingdom

    1 shared publication

Latest Publications

  • Nitrosothiols in Bacterial Pathogens and Pathogenesis

    by Jay R. Laver, Samantha McLean, Lesley A.H. Bowman, Laura J. Harrison, Robert C. Read, Robert K. Poole

    The formation and degradation of S-nitrosothiols (SNOs) are important mechanisms of post-translational protein modification and appear to be ubiquitous in biology. These processes play well-characterized roles in eukaryotic cells, including a variety of pathologies and in relation to chronic conditions. We know little of the roles of these processes in pathogenic and other bacteria. It is clear, mostly from growth and transcriptional studies, that bacteria sense and respond to exogenous SNOs. These responses are phenotypically and mechanistically distinct from the responses of bacteria to nitric oxide (NO) and NO-releasing agents, as well as peroxynitrite. Small SNOs, such as S-nitrosoglutathione (GSNO), are accumulated by bacteria with the result that intracellular S-nitrosoproteins (the 'S-nitrosoproteome') are detectable. Recently, conditions for endogenous SNO formation in enterobacteria have been described. The propensity of intracellular proteins to form SNOs is presumably constrained by the same rules of selectivity that have been discovered in eukaryotic systems, but is also influenced by uniquely bacterial NO detoxification systems, exemplified by the flavohemoglobin Hmp in enterobacteria and NO reductase of meningococci. Furthermore, the bacterial expression of such proteins impacts upon the formation of SNOs in mammalian hosts. The impairment during bacterial infections of specific SNO events in the mammalian host is of considerable interest in the context of proteins involved in innate immunity and intracellular signalling. In bacteria, numerous mechanisms of S-nitrosothiol degradation have been reported (e.g., GSNO reductase); others are thought to operate, based on consideration of their mammalian counterparts. The nitrosothiols of bacteria and particularly of pathogens warrant more intensive investigation.


  • Open Access

    Bacterial nitric oxide detoxification prevents host cell S‐nitrosothiol formation: a novel mechanism of bacterial pathogenesis

    by Jay R. Laver, Tania M. Stevanin, Sarah L. Messenger, Amy Dehn Lunn, Margaret E. Lee, James W. B. Moir, Robert K. Poole, Robert C. Read

    Snitrosylation is an important mediator of multiple nitric oxide‐dependent biological processes, including eukaryotic cellular events such as macrophage apoptosis and proinflammatory signaling. Many pathogenic bacteria possess NO detoxification mechanisms, such as the nitric oxide reductase (NorB) of Neisseria meningitidis and the flavohemoglobins (Hmp) of Salmonella entérica and Escherichia coli, which serve to protect the microorganism from nitrosative stress within the in‐tracellular environment. In this study, we demonstrate that expression of meningococcal NorB increases the rate at which low‐molecular‐weight S ‐nitrosothiol (SNO) de‐composes in vitro. To determine whether this effect occurs in cells during infection by bacteria, we induced SNO formation in murine macrophages byactivation with lipopolysaccharide and ‐/‐interferon and observed a reduced abundance of SNO during coincubation with N. meningitidis, S. enterica, or E. coli. In each case, this effect was shown to be dependent on bacterial NO detoxification genes, which act to prevent SNO formation through the removal of NO. This may represent a novel mechanism of host cell injury by bacteria.—Laver, J. R., Steva‐nin, T. M., Messenger, S. L., Dehn Lunn, A., Lee, M. E., Moir, J. W. B., Poole, R. K., Read, R. C. Bacterial nitric oxide detoxification prevents host cell S‐nitrosothiol formation: a novel mechanism of bacterial pathogenesis. FASEB J . 24, 286–295 (2010). www.fasebj.org